A number of research firms have changed their ratings and price targets for Universal Health Services (NYSE: UHS):

  • 7/13/2017 – Universal Health Services was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Universal Health’s robust inorganic growth has substantially contributed to strong revenue generation. Moreover, the U.S healthcare industry offers immense untapped opportunities given the rising numbers of baby boomers. Also, solid Acute-care Platform continues to perform well. The company is scheduled to report its second quarter results on Jul 25, after the market closes. The Zacks Consensus Estimate is pegged at $2.07 for the second quarter, reflecting 6.7% year over year growth. Well reflective of the positives, over last six months, the company’s shares have gained 9%, outperforming the 6% increase of the Zacks categorized Hospital industry. However, Universal Health remains exposed to integration risks owing to several acquisitions. Further, the company’s highly leveraged balance sheet a major headwind. The company is also expected witness margin contraction at both acute care and behavioral hospitals.”
  • 7/4/2017 – Universal Health Services was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $137.00 price target on the stock. According to Zacks, “Universal Health’s robust inorganic growth has substantially contributed to strong revenue generation. Moreover, the U.S healthcare industry offers immense untapped opportunities given the rising numbers of baby boomers. Also, solid Acute-care Platform continues to perform well. The Zacks Consensus Estimate is pegged at $2.07 for the to-be-reported quarter, reflecting 6.7% year over year growth. However, year to date, the company’s shares have gained 15%, underperforming the 18% increase of the Zacks categorized Hospital industry. Universal Health remains exposed to integration risks owing to several acquisitions. Further, the company’s highly leveraged balance sheet a major headwind. The company is also expected witness margin contraction at both acute care and behavioral hospitals.”
  • 6/29/2017 – Universal Health Services was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating.
  • 6/28/2017 – Universal Health Services was downgraded by analysts at Zacks Investment Research from a “hold” rating to a “sell” rating. According to Zacks, “Year to date, the company’s shares have gained 9%, underperforming the 16% increase of the Zacks categorized Hospital industry. Universal Health remains exposed to integration risks owing to several acquisitions. Further, the company’s highly leveraged balance sheet a major headwind. The company is also expected witness margin contraction at both acute care and behavioral hospitals. The Zacks Consensus Estimate, although increased for 2017 in last thirty days, it has significantly declined for 2018. However, its robust inorganic growth has also contributed to strong revenue generation. Moreover, the U.S healthcare industry offers immense untapped opportunities given the rising numbers of baby boomers. Also, solid Acute-care Platform continues to perform well. The Zacks Consensus Estimate is pegged at $2.07 for the to-be-reported quarter, reflecting 6.7% year over year growth.”
  • 6/9/2017 – Universal Health Services was downgraded by analysts at BidaskClub from a “sell” rating to a “strong sell” rating.
  • 6/6/2017 – Universal Health Services is now covered by analysts at Morgan Stanley. They set an “equal weight” rating and a $124.00 price target on the stock.

Universal Health Services, Inc. (NYSE UHS) traded down 0.05% during mid-day trading on Monday, hitting $124.10. 710,873 shares of the company were exchanged. The company has a market cap of $12.00 billion, a price-to-earnings ratio of 16.94 and a beta of 1.08. Universal Health Services, Inc. has a 12-month low of $99.72 and a 12-month high of $138.77. The stock’s 50 day moving average is $116.76 and its 200-day moving average is $117.42.

Universal Health Services (NYSE:UHS) last issued its earnings results on Tuesday, April 25th. The health services provider reported $2.10 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.07 by $0.03. Universal Health Services had a net margin of 7.23% and a return on equity of 15.99%. The company had revenue of $2.61 billion for the quarter, compared to the consensus estimate of $2.65 billion. During the same quarter in the previous year, the company earned $1.98 EPS. The firm’s revenue for the quarter was up 6.7% compared to the same quarter last year. Equities research analysts predict that Universal Health Services, Inc. will post $8.00 EPS for the current year.

Universal Health Services, Inc is a holding company. The Company’s principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities, and behavioral healthcare facilities. The Company’s segments include Acute Care Hospital Services, Behavioral Health Services and Other.

Receive News & Ratings for Universal Health Services Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services Inc and related companies with MarketBeat.com's FREE daily email newsletter.